Tumor Profiling Market Size, Share & Trends Analysis Report By Technique (Genomics, Proteomics), By Technology, By Application (Personalized Cancer Medicine, Oncological Diagnostics, Research), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Treadmill Ergometer Market Growth & Trends
The global treadmill ergometer market size is expected to reach USD 5.60 billion by 2030, registering a CAGR of 8.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising health consciousness coupled with adoption of a healthy lifestyle is anticipated to drive the growth. Treadmill ergometer provide personalized feedback, which is expected to positively influence the product demand. Increasing preference for physical activities such as walking and running has drawn attention toward fitness tracking and is expected to bode well for the market growth.
Treadmill ergometer provide real-time health metrics such as workout duration, distance travelled, speed, and calories burned. High tech ergometer also showcase blood pressure levels and oxygen uptake. Rising preference for real-time fitness tracking is expected to drive the demand for equipment integrated with advanced technology over their traditional counterparts. This factor is anticipated to propel the demand for treadmill ergometer in the fitness industry over the forecast period.
Walking and running are some of the most popular fitness activities and thus, an increasing number of consumers is likely to opt for exercising tools with real-time data to enhance their overall workout experience. Moreover, increasing product innovation is expected to boost the demand for motorized and smart fitness equipment. For instance, introduction of stair-treadmill ergometer, which is a combination of standard stepper and a treadmill has positively influenced the product demand for effective cardio exercising.
Rising incidence of trauma and deaths caused by cardiovascular diseases is anticipated to create awareness regarding the importance of regular exercise and leading a healthy lifestyle. As a result, rising number of gyms and fitness clubs coupled with demand from hospitals and rehabilitation centers is projected to fuel the global market growth. According to the American Heart Association (AHA), in 2016, Coronary Heart Disease (CHD) was the leading cause of death in U.S. with around 43.2% deaths caused by cardiovascular diseases.
Fitness club application segment held the largest market share of more than 82.9% in 2018. Rising awareness regarding the importance of physical activities coupled with increased participation in fitness and sports activities is projected to drive the growth. Consumer preference for cardiovascular exercises and strength training is expected to bode well for the treadmill ergometer demand in the forthcoming years.
Commercial end user segment held the largest market share of around 85% in 2018. Rising demand for treadmill ergometers from sports clubs, fitness clubs, gyms, offices, and medical centers among others is projected to drive the segment growth. Moreover, increasing construction of such commercial spaces is likely to positively influence the product demand.
North America held the largest share of 41.0% in the treadmill ergometer market in 2018. Availability of a wide assortment of products to monitor the progress of workout sessions, has fueled the regional market growth. U.S. dominates the global market due to high consumer willingness to spend on fitness and health rehabilitation.
Treadmill Ergometer Market Report Highlights
Treadmill Ergometer Market Growth & Trends
The global treadmill ergometer market size is expected to reach USD 5.60 billion by 2030, registering a CAGR of 8.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising health consciousness coupled with adoption of a healthy lifestyle is anticipated to drive the growth. Treadmill ergometer provide personalized feedback, which is expected to positively influence the product demand. Increasing preference for physical activities such as walking and running has drawn attention toward fitness tracking and is expected to bode well for the market growth.
Treadmill ergometer provide real-time health metrics such as workout duration, distance travelled, speed, and calories burned. High tech ergometer also showcase blood pressure levels and oxygen uptake. Rising preference for real-time fitness tracking is expected to drive the demand for equipment integrated with advanced technology over their traditional counterparts. This factor is anticipated to propel the demand for treadmill ergometer in the fitness industry over the forecast period.
Walking and running are some of the most popular fitness activities and thus, an increasing number of consumers is likely to opt for exercising tools with real-time data to enhance their overall workout experience. Moreover, increasing product innovation is expected to boost the demand for motorized and smart fitness equipment. For instance, introduction of stair-treadmill ergometer, which is a combination of standard stepper and a treadmill has positively influenced the product demand for effective cardio exercising.
Rising incidence of trauma and deaths caused by cardiovascular diseases is anticipated to create awareness regarding the importance of regular exercise and leading a healthy lifestyle. As a result, rising number of gyms and fitness clubs coupled with demand from hospitals and rehabilitation centers is projected to fuel the global market growth. According to the American Heart Association (AHA), in 2016, Coronary Heart Disease (CHD) was the leading cause of death in U.S. with around 43.2% deaths caused by cardiovascular diseases.
Fitness club application segment held the largest market share of more than 82.9% in 2018. Rising awareness regarding the importance of physical activities coupled with increased participation in fitness and sports activities is projected to drive the growth. Consumer preference for cardiovascular exercises and strength training is expected to bode well for the treadmill ergometer demand in the forthcoming years.
Commercial end user segment held the largest market share of around 85% in 2018. Rising demand for treadmill ergometers from sports clubs, fitness clubs, gyms, offices, and medical centers among others is projected to drive the segment growth. Moreover, increasing construction of such commercial spaces is likely to positively influence the product demand.
North America held the largest share of 41.0% in the treadmill ergometer market in 2018. Availability of a wide assortment of products to monitor the progress of workout sessions, has fueled the regional market growth. U.S. dominates the global market due to high consumer willingness to spend on fitness and health rehabilitation.
Treadmill Ergometer Market Report Highlights
- In terms of regional revenue, North America held the largest share of the treadmill ergometer market in 2023
- The commercial segment dominated the market having 86.6% share in 2023. This is due to increasing number of health clubs, gyms, and rehabilitation centers
- Sports & fitness clubs dominated the market with 34.5% of revenue share in 2023. The increasing emphasis on physical fitness and wellness has led to a surge in gym memberships globally.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. TUMOR PROFILING MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Tumor Profiling Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. TUMOR PROFILING MARKET: TECHNIQUE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Tumor Profiling Market: Technique Movement Analysis, USD Million, 2023 & 2030
4.3. Genomics
4.3.1. Genomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Proteomics
4.4.1. Proteomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Metabolomics
4.5.1. Metabolomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Epigenetics
4.6.1. Epigenetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. TUMOR PROFILING MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Tumor Profiling Market: Technology Movement Analysis, USD Million, 2023 & 2030
5.3. Sequencing Techniques
5.3.1. Sequencing Techniques Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. NGS
5.3.2.1. NGS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Sanger Sequencing
5.3.3.1. Sanger Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. Pyro Sequencing
5.3.4.1. Pyro Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. In Situ Hybridization
5.4.1. In Situ Hybridization Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Immunohistochemistry
5.5.1. Immunohistochemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. qPCR
5.6.1. qPCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Microarray
5.7.1. Microarray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. TUMOR PROFILING MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Tumor Profiling Market: Application Movement Analysis, USD Million, 2023 & 2030
6.3. Personalized Cancer Medicine
6.3.1. Personalized Cancer Medicine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Oncological Diagnostics
6.4.1. Oncological Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Research
6.5.1. Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Cancer Research
6.5.2.1. Cancer Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Biomarker Discovery
6.5.3.1. Biomarker Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. TUMOR PROFILING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Tumor Profiling Market Share, By Region, 2023 & 2030, USD Million
7.2. North America
7.2.1. North America Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Illumina, Inc.
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. QIAGEN
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Genomic Health
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Neogenomics Inc.
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Life Sciences
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Oxford Gene Technology
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Bruker Spatial Biology, Inc.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Ribomed Biotechnologies Inc.
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. GenomeDX
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Guardant Health
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
8.4.11. FOUNDATION MEDICINE, INC.
8.4.11.1. Participant’s Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. TUMOR PROFILING MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Tumor Profiling Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. TUMOR PROFILING MARKET: TECHNIQUE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Tumor Profiling Market: Technique Movement Analysis, USD Million, 2023 & 2030
4.3. Genomics
4.3.1. Genomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Proteomics
4.4.1. Proteomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Metabolomics
4.5.1. Metabolomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Epigenetics
4.6.1. Epigenetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. TUMOR PROFILING MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Tumor Profiling Market: Technology Movement Analysis, USD Million, 2023 & 2030
5.3. Sequencing Techniques
5.3.1. Sequencing Techniques Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. NGS
5.3.2.1. NGS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Sanger Sequencing
5.3.3.1. Sanger Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. Pyro Sequencing
5.3.4.1. Pyro Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. In Situ Hybridization
5.4.1. In Situ Hybridization Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Immunohistochemistry
5.5.1. Immunohistochemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. qPCR
5.6.1. qPCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Microarray
5.7.1. Microarray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. TUMOR PROFILING MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Tumor Profiling Market: Application Movement Analysis, USD Million, 2023 & 2030
6.3. Personalized Cancer Medicine
6.3.1. Personalized Cancer Medicine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Oncological Diagnostics
6.4.1. Oncological Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Research
6.5.1. Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Cancer Research
6.5.2.1. Cancer Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Biomarker Discovery
6.5.3.1. Biomarker Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. TUMOR PROFILING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Tumor Profiling Market Share, By Region, 2023 & 2030, USD Million
7.2. North America
7.2.1. North America Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Illumina, Inc.
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. QIAGEN
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Genomic Health
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Neogenomics Inc.
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Life Sciences
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Oxford Gene Technology
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Bruker Spatial Biology, Inc.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Ribomed Biotechnologies Inc.
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. GenomeDX
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Guardant Health
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
8.4.11. FOUNDATION MEDICINE, INC.
8.4.11.1. Participant’s Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Recent Developments/ Strategic Initiatives
